Saradiya Chatterjee

Techno India University — India

Medicine · Health Sciences

2h-index111citations17works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Diagnosis and Treatment(8), Lung Cancer Treatments and Mutations(8), Radiomics and Machine Learning in Medical Imaging(4), Cancer Immunotherapy and Biomarkers(3), Immune Response and Inflammation(3)

Publications17 total

Emerging roles and therapeutic potential of non-coding RNA in osteosarcoma: a review
Medical Oncology·2025
Data from TLR7 Promotes Tumor Progression, Chemotherapy Resistance, and Poor Clinical Outcomes in Non–Small Cell Lung Cancer
2023Open Access
Data Supplement from TLR7 Promotes Tumor Progression, Chemotherapy Resistance, and Poor Clinical Outcomes in Non–Small Cell Lung Cancer
2023Open Access
Data from TLR7 Promotes Tumor Progression, Chemotherapy Resistance, and Poor Clinical Outcomes in Non–Small Cell Lung Cancer
2023Open Access
Data Supplement from TLR7 Promotes Tumor Progression, Chemotherapy Resistance, and Poor Clinical Outcomes in Non–Small Cell Lung Cancer
2023Open Access
Data Supplement from TLR7 Promotes Tumor Progression, Chemotherapy Resistance, and Poor Clinical Outcomes in Non–Small Cell Lung Cancer
2023Open Access
Data Supplement from TLR7 Promotes Tumor Progression, Chemotherapy Resistance, and Poor Clinical Outcomes in Non–Small Cell Lung Cancer
2023Open Access
PO-0952 A dynamically updating individualized survival prediction modelling tool for oral cancer
Radiotherapy and Oncology·2021
PO-1797: Dosimetric analysis of simultaneous integrated boost in the HYPORT Adjuvant Trial (NCT03788213)
Radiotherapy and Oncology·2020
The effect of insurance status on genetic testing patterns and outcomes for inheritable cancer syndromes: A single institution experience
Gynecologic Oncology·2018
76: Double whammy or double bonanza? Report of compound/double EGFR mutation in NSCLC patients from a cancer centre in Eastern India
Lung Cancer·2017
1: Tumours' Achilles' heel, that never was – Experience of re-biopsy on disease progression on EGFR-TKIs in lung cancer (NSCLC) patients from a Cancer Centre in Eastern India
Lung Cancer·2017· 2 cited
Meghnad Saha - The Scientist and the Institution Builder
SHILAP Revista de lepidopterología·2015Open Access
TLR7 Promotes Tumor Progression, Chemotherapy Resistance, and Poor Clinical Outcomes in Non–Small Cell Lung Cancer
Cancer Research·2014· 107 cited
Role of TLR7 in non-small cell lung carcinona (NSCLC)
OpenGrey (Institut de l'Information Scientifique et Technique)·2013
843 poster IS SAFE DOSE ESCALATION POSSIBLE IN OROPHARNGEAL SCC: RESULTS OF THE VORTIGERN STUDY
Radiotherapy and Oncology·2011
1st EFIS‐EJI Intensive Course in Clinical Immunology: Towards a new era in Immunology
European Journal of Immunology·2011· 2 citedOpen Access

Frequent Co-authors

Lucile Crozet(7), Diane Damotte(7), Kristina Iribarren(7), Catherine Schramm(7), Marco Alifano(7), Julien Cherfils‐Vicini(7), Jérémy Goc(7), Sandrine Katsahian(7), Marie‐Caroline Dieu‐Nosjean(7), Wolf H. Fridman(7), Catherine Sautès‐Fridman(7), Isabelle Cremer(7), Audrey Lupo(6), Mohammad K. Younes(6), R.K. Shrimali(2), J. Bhargav(2), Nivedita Arora(2), Divya Midha(2), Dayananda Lingegowda(2), Deepak Dabkara(2)